The clinical determination of unique effect of potentiation of phenothiazine medication by nylidrin hydrochloride.
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy; D002389:Catatonia / Q000188:drug therapy; D003865:Major Depressive Disorder / Q000188:drug therapy; D004357:Drug Synergism; D006801:Humans; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines / Q000627:therapeutic use*; D010919:Placebos / Q000494:pharmacology; D011581:Psychological Tests; D012559:Schizophrenia / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010640:Phenothiazines; D010919:Placebos; D014665:Vasodilator Agents